SVA Stock Summary and Trading Ideas (Sinovac Biotech Ltd. - Ordinary Shares (Antigua/Barbudo) | NASDAQ:SVA)

Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

Sinovac Biotech Ltd. - Ordinary Shares (Antigua/Barbudo) trades on the NASDAQ stock market under the symbol SVA.

As of August 31, 2026, SVA stock price was flat at $6.47 with million shares trading.

SVA has a market cap of $464.94 million. This is considered a Small Cap stock.

In the last 3 years, SVA traded as high as $6.47 and as low as $6.47.

SVA has underperformed the market in the last year with a return of 0.0%, while the SPY ETF gained +19.4%. In the last 3 month period, SVA fell short of the market, returning 0.0%, while SPY returned +1.9%. However, in the most recent 2 weeks SVA has outperformed the stock market by returning 0.0%, while SPY returned -1.2%.

SVA support price is $6.47 and resistance is $6.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SVA shares will trade within this expected range on the day.